Hyperliquid Strategies Inc - Common Stock (PURR)

MIAMI, July 08, 2026 (GLOBE NEWSWIRE) -- Defiance ETFs, a leader in thematic and leveraged exchange-traded funds, today announced the launch of the Defiance Daily Target 2X Long PURR ETF (Nasdaq: PUR), the first ETF designed to provide 2X daily leveraged exposure to Hyperliquid Strategies Inc. (Nasdaq: PURR). Now trading, PUR gives active traders amplified, single-ticker exposure to PURR, a digital asset treasury and investment company focused on the Hyperliquid Layer-1 blockchain ecosystem and its native token, HYPE.

As pharmaceutical companies race to develop treatments for metabolic dysfunction–associated steatohepatitis (MASH) and related steatotic liver disease (SLD), one critical piece of the healthcare puzzle is drawing increasing attention: how to diagnose and monitor millions of patients at scale . While most investor focus remains on drug developers, ENDRA Life Sciences (NASDAQ: NDRA) is positioning itself on the infrastructure side of the emerging MASH ecosystem with its innovative TAEUS® (Thermo-Acoustic Enhanced UltraSound) liver imaging technology.